The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
PAX5/TEL Acts as a Transcriptional Repressor Causing Down-modulation of CD19, Enhances Migration to CXCL12, and Confers Survival Advantage in pre-BI Cells
Published version of a preprint
Abstract
PAX5 is a transcription factor essential for B-cell development. Recently, it has been found as a frequent target of aberrancies in childhood acute lymphoblastic leukemia (ALL; 30% of B cell ALL cases), showing monoallelic loss, point mutations, or chromosomal translocations. The role of these aberrancies is still poorly understood. We previously cloned the PAX5/TEL fusion gene in a patient affected by B-cell precursor ALL with a t(9;12) translocation. This is the first report investigating the molecular and functional roles of PAX5/TEL protein in vitro from murine wild-type pre-BI cells. We showed that PAX5/TEL protein acts as an aberrant transcription factor with repressor function, recruiting mSin3A, down-regulating B220, CD19, BLNK, MB-1, FLT3, and μ heavy chain expression, thus suggesting a block on B-cell differentiation. In a PAX5-deficient context, the presence of PAX5/TEL did not replace PAX5 functions. PAX5/TEL protein enhances cell migration towards CXCL12, with the overexpression of CXCR4. Moreover, the presence of the fusion gene overcomes interleukin-7 withdrawal and interferes with transforming growth factor-β1 pathway, inducing resistance and conferring cells an advantage in proliferation and survival. Thus, in vitro, the PAX5/TEL protein has a dominant effect on wild-type PAX5, interferes with the process of B-cell differentiation and migration, and induces resistance to apoptosis. Taken together, these phenomena likely represent key events in the process of B-cell transformation. [Cancer Res 2008;68(1):181–9]
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The fusions include the PNT domain of ETV6 and the DNA-binding domain of either RUNX1 (Figure 1a) (164) or PAX5 (165, 166).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [166]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan-Smith, E., Dalton, J. D., Girtman, K., Mathew, S., Ma, J., Pounds, S. B., et al. (2007) · Nature · doi:10.1038/nature05690 · Cited by 1,801
Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
Nutt, S. L., Heavey, B., Rolink, A. G., & Busslinger, M. (1999) · Nature · doi:10.1038/44076 · Cited by 1,179
Self-citationCXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2006) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,170
Pax5: the guardian of B cell identity and function
Cobaleda, C., Schebesta, A., Delogu, A., & Busslinger, M. (2007) · Nature Immunology · doi:10.1038/ni1454 · Cited by 702
Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy
Jennings, C. D., & Foon, K. A. (1997) · Blood · doi:10.1182/blood.v90.8.2863 · Cited by 447
D'Apuzzo, M., Rolink, A., Loetscher, M., Hoxie, J. A., Clark‐Lewis, I., Melchers, F., Baggiolini, M., & Moser, B. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270729 · Cited by 327
Self-citationThe promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP.
Kozmik, Z., Wang, S., Dörfler, P., Adams, B., & Busslinger, M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2662 · Cited by 325
CD19 Antigen in Leukemia and Lymphoma Diagnosis and Immunotherapy
Scheuermann, R. H., & Racila, E. (1995) · Leukemia & Lymphoma · doi:10.3109/10428199509059636 · Cited by 323
Nutt, S. L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.8.2319 · Cited by 315
Self-citation
Cited by
Genomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
Transposable elements are the primary source of novelty in primate gene regulation
Trizzino, M., Park, Y., Holsbach-Beltrame, M., Aracena, K., Mika, K., Caliskan, M., Perry, G. H., Lynch, V. J., & Brown, C. D. (2017) · Genome Research · doi:10.1101/gr.218149.116 · Cited by 285
Medvedovic, J., Ebert, A., Tagoh, H., & Busslinger, M. (2011) · Advances in Immunology · doi:10.1016/b978-0-12-385991-4.00005-2 · Cited by 251
Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia
Nebral, K., Denk, D., Attarbaschi, A., König, M., Mann, G., Haas, O. A., & Strehl, S. (2009) · Leukemia · doi:10.1038/leu.2008.306 · Cited by 204
Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia
Somasundaram, R., Prasad, M. A. J., Ungerbäck, J., & Sigvardsson, M. (2015) · Blood · doi:10.1182/blood-2014-12-575688 · Cited by 135
Metadata
- Authors
- Fazio, G., Palmi, C., Rolink, A., Biondi, A., & Cazzaniga, G.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- 3University of Basel, Basel, Switzerland
- Azienda Ospedaliera San Gerardo (IT)
- Venue
- Cancer Research
- Published
- 2008-01-01
- Volume
- 68
- Issue
- 1
- Pages
- 181-189
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W1986199526
- Cited by
- 55
- References
- 50
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 4 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 2 · 2015: 6 · 2014: 4 · 2013: 1 · 2012: 4
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- PAX5, transcriptional repression, B-cell precursor acute lymphoblastic leukemia, CXCR4, mSin3A, TGF-β1 signaling, apoptosis resistance, B cell transformation
- MeSH terms
- Animals, B-Lymphocytes, Cell Movement, Cell Nucleus, Cell Survival, Cell Transformation, Neoplastic, Humans, Lymphocyte Activation, Repressor Proteins, Oncogene Proteins, Fusion, Down-Regulation, Interleukin-7, Gene Expression Regulation, Leukemic, Apoptosis, Antigens, CD19, Adaptor Proteins, Signal Transducing, Mice, PAX5 Transcription Factor, CD79 Antigens, fms-Like Tyrosine Kinase 3, Transforming Growth Factor beta1, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Chemokine CXCL12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PAX5/TEL Acts as a Transcriptional Repressor Causing Down-modulation of CD19, Enhances Migration to CXCL12, and Confers Survival Advantage in pre-BI Cells. https://app.cochat.ai/papers/10.1158/0008-5472.can-07-2778
- The paper
- Fazio, G., Palmi, C., Rolink, A., Biondi, A., & Cazzaniga, G. (2008). PAX5/TEL Acts as a Transcriptional Repressor Causing Down-modulation of CD19, Enhances Migration to CXCL12, and Confers Survival Advantage in pre-BI Cells. Cancer Research. https://doi.org/10.1158/0008-5472.can-07-2778
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.